Creotech Instruments SA
WSE:CRI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Creotech Instruments SA
WSE:CRI
|
PL |
|
A
|
Aerojet Rocketdyne Holdings Inc
LSE:0HA5
|
US |
|
VICI Properties Inc
NYSE:VICI
|
US |
|
Minco Silver Corp
TSX:MSV
|
CA |
|
O
|
Onelife Capital Advisors Ltd
NSE:ONELIFECAP
|
IN |
|
BioNexus Gene Lab Corp
NASDAQ:BGLC
|
MY |
|
C
|
Cardiol Therapeutics Inc
NASDAQ:CRDL
|
CA |
|
Capitol Health Ltd
ASX:CAJ
|
AU |
Wall Street
Price Targets
CRI Price Targets Summary
Creotech Instruments SA
According to Wall Street analysts, the average 1-year price target for CRI is 326.4 PLN with a low forecast of 323.2 PLN and a high forecast of 336 PLN.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CRI's stock price target?
Price Target
326.4
PLN
According to Wall Street analysts, the average 1-year price target for CRI is 326.4 PLN with a low forecast of 323.2 PLN and a high forecast of 336 PLN.
What is Creotech Instruments SA's Revenue forecast?
Projected CAGR
573%
For the last 4 years the compound annual growth rate for Creotech Instruments SA's revenue is -3%. The projected CAGR for the next 3 years is 573%.
